Literature DB >> 1898704

Quinine-induced immune thrombocytopenia associated with hemolytic uremic syndrome: a new clinical entity.

J L Gottschall1, W Elliot, E Lianos, J G McFarland, K Wolfmeyer, R H Aster.   

Abstract

Three patients are described who developed severe thrombocytopenia, microangiopathic hemolytic anemia, and acute renal failure after ingestion of quinine. In one patient, the same clinical findings recurred several months later after another exposure to quinine. Serum from one patient contained quinine-dependent IgG antibodies reactive with the platelet glycoprotein (GP) Ib/IX complex. In the second and third cases, serum contained IgG and IgM antibodies reactive with both the GP Ib/IX and IIb/IIIa complexes in the presence of quinine. Quinine appears to have induced both immune thrombocytopenia and the hemolytic uremic syndrome (HUS) in these individuals. Findings made in these cases may have implications for the pathogenesis of some forms of HUS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898704

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics.

Authors:  M Saha; J K McDaniel; X L Zheng
Journal:  J Thromb Haemost       Date:  2017-07-27       Impact factor: 5.824

2.  Discovery of a Plasmodium falciparum glucose-6-phosphate dehydrogenase 6-phosphogluconolactonase inhibitor (R,Z)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-(2-fluorobenzylidene)-3-oxo-3,4-dihydro-2H-benzo[b][1,4]thiazine-6-carboxamide (ML276) that reduces parasite growth in vitro.

Authors:  Janina Preuss; Patrick Maloney; Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Palak Gosalia; Monika Milewski; Yujie Linda Li; Eliot Sugarman; Becky Hood; Eigo Suyama; Kevin Nguyen; Stefan Vasile; Eduard Sergienko; Arianna Mangravita-Novo; Michael Vicchiarelli; Danielle McAnally; Layton H Smith; Gregory P Roth; Jena Diwan; Thomas D Y Chung; Esther Jortzik; Stefan Rahlfs; Katja Becker; Anthony B Pinkerton; Lars Bode
Journal:  J Med Chem       Date:  2012-08-06       Impact factor: 7.446

Review 3.  Thrombotic thrombocytopenic purpura: survival by "giving a dam".

Authors:  Joel L Moake
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

4.  Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities.

Authors:  Mark A Howard; Andrea B Hibbard; Deirdra R Terrell; Patrick J Medina; Sara K Vesely; James N George
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

Review 5.  Thrombotic Microangiopathy and the Kidney.

Authors:  Vicky Brocklebank; Katrina M Wood; David Kavanagh
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 8.237

6.  Drug-induced thrombocytopenia for the hospitalist physician with a focus on heparin-induced thrombocytopenia.

Authors:  Matthew T Rondina; Amanda Walker; Robert C Pendleton
Journal:  Hosp Pract (1995)       Date:  2010-04

7.  Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies.

Authors:  Daniel W Bougie; Peter R Wilker; Richard H Aster
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

Review 8.  Safety and tolerability of fluoroquinolones.

Authors:  S R Norrby; P S Lietman
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 9.  Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.

Authors:  W N Patton; S B Duffull
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

Review 10.  Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and management.

Authors:  R H Aster; B R Curtis; J G McFarland; D W Bougie
Journal:  J Thromb Haemost       Date:  2009-04-02       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.